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Background: Fumaria parviflora Lam. (Fumaraceae) is widely used in traditional as well as folkloric system of
medicine from ancient. It is commonly known as ‘Pitpapra’ or ‘Shahtrah’ in Indian traditional system of medicine
and used for treating numerous ailments like diarrhea, fever, influenza, blood purifier and other complications. The
object of the present study was to evaluate the Antileishmanial, antibacterial, antifungal and cytotoxic potential of
isolated compound.
Methods: Methanolic extract of whole plant of Fumaria parviflora was dried under reduced pressure to obtain a
dark brown residue which was adsorbed on silica gel column grade (60–120 mesh) to obtain a slurry and
chromatographed over silica gel loaded column in petroleum ether – chloroform (3:1, 1:1 and 1:3 v/v). The in vitro
antileishmanial evaluation of isolated compound against Leishmania donovani promastigotes was investigated by
growth kinetics assay, reversibility assay, analysis of cellular morphology, adverse toxicity and determination of 50%
growth inhibitory concentration (GI50). Disc diffusion and broth micro dilution methods were used to study the
antibacterial (Gram + Staphylococcus epidermidis and Bacillus subtilis; Gram - Escherichia coli and Salmonella
typhimurium) and antifungal (Candida albicans and Aspergillus niger) potential in vitro.
Results: Structure elucidation by spectral data analysis revealed a novel compound, n-octacosan-7β-ol (OC), yield
(0.471%), having significant antimicrobial activity against Leishmania donovani promastigotes, Staphylococcus
epidermidis, Escherichia coli, Candida albicans and Aspergillus niger in vitro with GI50 = 5.35, MIC 250, MIC 250 and
MFC 500 and MIC 250 μg ml-1 respectively. The isolated compound did not show adverse effect against mammalian
macrophages.
Conclusions: The available evidence of compound suggested that it may be used as antimicrobial agent in future
and may provide new platform for drug discovery programmes for leishmaniasis.
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The traditional medicine has been a vibrant, innovation-
driven highly successful component of global industry and
confluence of spectacular advances in chemistry, mole-
cular biology, genomics and the cognate fields of spectros-
copy, chromatography and crystallography led to the new
findings and development of numerous novel curative
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unless otherwise stated.[1]. They have formed the basis of sophisticated traditional
medicine systems among which Ayurvedic, Unani and
Chinese systems have given ascent to crucial unmatched
lead molecules still in use today [2]. The number of higher
medicinal plant species on this planet is estimated at
250,000 [3] but of these only about 6% have been screened
for biological activity, 15% have been evaluated phyto-
chemically [4] and only about 0.75% herbal drugs have
been studied in clinical trials [5]. So the search for new
molecules nowadays has taken a faintly different route
where the science of ethanomedicine is being used as aLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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classes of molecules [2].
Fumaria parviflora Lam. is widely used in traditional and
as well as folkloric system of medicine named as “fumitory,
earth smoke, beggary, fumus, vapor and fumitory or wax
dolls” in English [6]. It is locally known as ‘Pitpapra’ or
‘Shahtrah’ in India [7], “Homaira” in Saudi Arabia [8].
Phytochemical investigation of this medicinal plant re-
vealed the presence of several alkaloids [9,10], and shown
to possess pharmacological activities like antipyretic [11],
hepatoprotective [12], hypoglycemic [13], antidiarrheal,
antispasmodic, bronchodilator [14], anthelmintic [15],
antieczema [16] and nematocidal activities [17].
Visceral leishmaniasis is an infectious disease caused by
protozoan parasite, leishmania donovani which is consi-
dered as a major public health trouble in developing coun-
tries [18]. Primary health care systems are not always
significant to use the herbal medicines in common practice
because very few studies were carried out to investigate the
potential use of these medicinal plants in treatment of para-
sitic diseases [19]. The chemotherapeutic interventions
against visceral leishmaniasis (VL) are limited and facing se-
vere concerns of toxicity, high cost, and drug resistance
[20]. In view of that concern an integrated approach to-
wards the discovery and development of novel chemical
entity with ethanopharmacological implications for pro-
motion and development of leads for leishmaniasis as well
as traditional medicine, remains a significant hope in the
current, target-rich scenario which may offer unprece-
dented diversity in structures and bioactivity. So isolation,
characterization and antimicrobial evaluation has been
aimed for novel bioactive compound by chromatographicFigure 1 Proton NMR spectrum of OC, at 400 MHz in CDCl3.techniques, and bacterial strain (Gram + Staphylococcus
epidermidis and Bacillus subtilis; Gram - Escherichia coli
and Salmonella typhimurium), fungal strain (Candida




M199 medium, RPMI 1640 medium were obtained from
Sigma-Aldrich, fetal bovine serum (FBS) from Gibco-
BRL, DMSO from SRL and methanol from Merck. All
other chemicals were from Sigma-Aldrich unless other-
wise stated. Melting point was determined on a Perfit
apparatus without correction. The IR spectrum was mea-
sured in KBr pellet on a Bio-Red FT-IR spectrometer. UV
spectrum was obtained in methanol with a Lambda Bio 20
spectrometer, 1H (400 MHz), 13C (100 MHz), NMR spec-
tra were recorded on Bruker spectrospin spectrometer.
CDCl3 (sigma-Aldrich) were used as solvent and TMS as
an internal standard. ESI- MS analysis was performed
on a Synapt Mass spectrometer (Waters) equipped with
direct inlet probe system. Column chromatography se-
parations were carried out on column grade silica gel
(Merck, 60–120 mesh). Precoated silica gel plates (Merck,
Silica gel 60 F254) were used for analytical thin layer chro-
matography (TLC) visualized by exposure to iodine and
UV radiations. Microbial strains used for the antimicrobial
evaluation, a panel which included laboratory control
bacterial strains (Gram + Staphylococcus epidermidis and
Bacillus subtilis; Gram - Escherichia coli and Salmonella
typhimurium) fungal strains (Candida albicans and
Aspergillus niger), and Leishmania donovani promastigote.
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used for positive and negative control respectively.Methods
Plant material
The Fumaria parviflora Lam. (whole plant) was collected
from the herbal garden of Jamia Hamdard, New Delhi and
identified by Prof. Javed Ahmad, Incharge herbal garden.
A specimen voucher of the drug was deposited to the
Phytochemistry Research Lab (PRL) with a reference
number PRL-JH/2011/05.Figure 3 1H–1H COSY spectrum of OC at 400 MHz in CDCl3.Parasite culture
L. donovani strain AG83 was a kind gift from Dr. Nahid
Ali (IICB, Kolkata, India) and was maintained in vivo in
BALB/c mice. Promastigotes were maintained in medium
M199 supplemented with 100 U ml-1sodium penicillin G
and 100 μg ml streptomycin1 sulfate (incomplete medium)
and 10% heat-inactivated FBS at 22°C, and subcultured
every 72 h in the same medium at a mean density of
2 × 106 cells/ml [21].Preparation of crude extract and isolation
The dried F. parviflora Lam. whole plant (1.25 kg) was
coarsely powdered and extracted with methanol for 72 h
using a Soxhlet extractor. The extract was dried under re-
duced pressure to obtain a dark brown residue (190 g).
The residue (100 g) was dissolved in minimum amount of
methanol and adsorbed on silica gel column grade (60–
120 mesh) to obtain slurry. The slurry was dried in air and
chromatographed over silica gel column loaded in pe-
troleum ether. The column was eluted with petroleum
ether and petroleum ether –chloroform (3:1, 1:1, 1:3 v/v)
mixtures.Figure 2 Carbon NMR spectrum of OC, at 100 MHz in CDCl3.General procedure for antimicrobial evaluation
Antimicrobial activity
Agar disc diffusion method and broth microdilution me-
thod were employed for the determination of antibacterial
and antifungal activities. The minimum inhibitory concen-
tration (MIC), minimum bactericidal (MBC), minimum
fungicidal concentration (MFC) [22] and the inhibition
zone of the OC against the test microorganisms were
determined by the broth microdilution method. The MIC,
MBC, MFC and the inhibition zone of the n-octacosan-
7β-ol (OC) were also determined in parallel experiments in
order to control the sensitivity of the test microorganisms.
A suspension of the bacterial strain (Gram+Staphylococ-
cus epidermidis and Bacillus subtilis; Gram - Escherichia
coli and Salmonella typhimurium), fungal strain (Candida
albicans and Aspergillus niger) (0.1 ml of 105 CFU ml-1)
was spread on the solid media plates. Nutrient agar and
Czapek Dox Agar sterilized in a flask and cooled to
45~ 50°C were distributed to sterilized Petri dishes with a
diameter of 9 cm (15 ml). The filter paper discs (6 mm in
diameter) were individually impregnated with 50 μl (1000
μg ml-1) of the OC and then placed onto the agar plates
which had previously been inoculated with the tested mi-
croorganisms. The plates were inoculated with bacterial
strains incubated at 37°C for 24 h and at 28°C for 48 h forFigure 4 N-octacosan-7β-ol (OC).
Table 1 Antibacterial and antifungal activities of OC as inhibition zones (mm)
Treatment OC Control Streptomycin Amphotericin B
Microorganism
Staphylococcus epidermidis (Gram +) 14 6 24 -
Bacillus subtilis (Gram +) 6 6 17 -
Escherichia coli (Gram -) 11 6 16.5 -
Salmonella typhimurium (Gram -) 6 6 18 -
Candida albicans 12 6 - 17
Aspergillus niger 11.5 6 - 15.5
(−) no activity, OC (n-octacosan-7β-ol), Control (The filter paper discs, 6 mm, without drug were taken as control), Streptomycin (Positive control for bacterial
strain) and Amphotericin B (Positive control for fungal strain).
Jameel et al. BMC Complementary and Alternative Medicine 2014, 14:98 Page 4 of 9
http://www.biomedcentral.com/1472-6882/14/98the fungal strains. The diameters were measured in milli-
meters. Streptomycin (10 μg/disk) was used as a positive
control for bacteria, amphotericin B (5 μg/disk) as a posi-
tive control for fungi, and DMSO was used as the negative
control. All assays were done in duplicate. A broth micro-
dilution method was used to determine the MIC, MBC
and MFC according to the National Committee for Cli-
nical Laboratory Standards [23]. All tests were performed
in Nutrient broth and Czapek-Dox broth supplemented
with ethanol at final concentration of 0.5% (v/v) for all mi-
croorganisms. Two folds serial dilutions of the OC were
prepared in a 96-well microtiter plate ranged from 1000
μg ml-1 to 1.038 μg ml-1. Overnight broth cultures of each
strain were prepared and the final concentration in each
well was adjusted to 105 CFU ml-1for bacterial strains and
fungal strains. 96-well microtiter plate injected with fungal
strain was incubated at 28°C for 48 h, and the bacteria
were incubated at 37°C for 24 h. The MIC is defined as
the lowest concentration of the OC at which the micro-
organism does not demonstrate visible growth. To deter-
mine MBC and MFC, 10 μl broth was taken from each
well and inoculated in Nutrient for 24 h at 37°C for bac-
teria or in Czapek Dox Agar for 48 h at 28°C for the fungi.
The MBC is defined as the lowest concentration of the
OC at which inoculated bacteria were completely killed.Table 2 Minimum inhibitory concentrations (MIC), minimum b
fungicidal concentrations (MFC) of OC
Treatment OC (μg/ml)
Microorganism
Staphylococcus epidermidis MIC 250
MBC 250
Escherichia coli MIC 250
MBC 500
Candida albicans MIC 500
MFC 500
Aspergillus niger MIC 250
MFC 500
(−) no activity, OC (n-octacosan-7β-ol), Streptomycin (Positive control for bacterial sThe MFC is defined as the lowest concentration of the
OC at which inoculated fungi were completely killed. All
determinations were performed in duplicate and two
growth controls consisting of Nutrient Agar and Czapek
Dox agar medium were included. The streptomycin and
amphotericin B served as a positive control.Growth kinetics assay
Promastigotes of L. donovani strain MHOM/IN/83/AG83
(2 × 106 cells ml-1) were incubated in the presence of OC
in M199 containing 10% FBS (complete medium) at a
concentration of 100 μg ml-1. Pentamidine (100 μg ml-1)
served as the reference antileishmanial drug, while 0.2%
DMSO, which represented the highest concentration in
the test compound, was used as a solvent control. Para-
sites in medium alone were taken as control. Viable para-
sites were enumerated for 7 days using a phase-contrast
microscope under a 40X objective [24].Growth reversibility assay
To confirm the leishmanicidal effect of OC, treated and
untreated parasites after 7 days of incubation were washed
twice with incomplete medium and finally resuspended in
complete medium and cultured at 22°C for a further 96 h.actericidal concentrations (MBC) and minimum









train) and Amphotericin B (Positive control for fungal strain).
Figure 5 Analysis of anti-promastigote activity of OC. Exponential
phase promastigotes (2 × 106 cells ml-1) of L. donovani were
incubated with 100 μg ml-1 of OC for different time points as
described in Methods. Each point corresponds to the mean ± SE of
triplicate samples and is representative of one of three independent
experiments.
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copically [24].Analysis of cellular morphology
Morphology of the promastigotes was evaluated after 96 h
of treatment with the test OC, pentamidine and or 0.2%
DMSO and photomicrographs were taken at 400x magni-
fication under phase-contrast microscope [25].Determination of GI50
To determine the GI50 (concentration of compound that
inhibited growth of parasites by 50%), promastigotes at a
density of 2 × 106 cells ml-1 were incubated in triplicate
with or without OC at serial three fold dilutions starting
from 100 μg ml-1 for 96 h. Pentamidine served as the
reference drug [26].Figure 6 Analysis of cellular morphology of OC treated promastigote
with 100 μg ml-1OC for 96 h and analyzed by light microscopy (400X) as dCytotoxicity to mammalian cells
Macrophages were collected by peritoneal lavage from
starch-stimulated mice. Peritoneal cells were collected in
RPMI 1640 medium (incomplete), pelleted by centri-
fugation at 800 x g for 10 min at 4°C, washed twice and
finally resuspended in complete medium. Macrophages
at a cell density of 1 × 106 cells ml-1 were incubated with
OC at varying concentrations for 48 h in a CO2 incu-
bator (5% CO2, 37°C). Pentamidine served as reference
drug and 0.2% DMSO as solvent control. Macrophages
without any treatment were taken as control. Cells were
observed under phase-contrast microscope and viability
was ascertained after trypan blue staining [26].
Results
Structural elucidation of isolated compound
Elution of the column with ratio of petroleum ether-
chloroform afforded star-shaped colorless of OC, recrystal-
lized from chloroform-methanol (1:1), 3.1 g (0.471% yield);
Rf 0.54 ± 0.02 (petroleum ether-chloroform, 1:1 v/v), m.p.
74–75°C; UV λ max (MeOH); 209 nm (log ε 3.6); IR λ max
(KBr); 3318, 2954, 2848, 1465, 1378, 1236, 1134, 857, 721
cm−1; 1H NMR (CDCl3); δ 3.67 (1H, brm, w1/2 = 14.1 Hz,
H-7α), 2.36 (2H, m H2 -6), 2.14 (2H m, H2-8), 1.70 (4H, m,
2xCH2), 1.51 (8H, m, 4x CH2), 1.34 (34H, 17x CH2), 0.98
(3H, t, J= 6.0, Me-1), 0.95 (3H, t, J= 6.8, Me-28); 13C NMR
(CDCl3); δ 72.06 (C-7), 37.50 (CH2), 31.95 (CH2), 31.91
(CH2), 29.73 (6x CH2), 29.67 (7x CH2), 29.61 (5x CH2),
29.40 (CH2), 29.36 (CH2), 25.68 (CH2), 22.72 (CH2), 14.16
(Me-1, Me-28). +ve ESI-MS m/z (rel. int.); 411 [M+1]+
(9.6), (C28H59O), 325(100).
The compound OC designated as octacosyl alcohol was
obtained as star-shaped colorless from ratio of petroleum
ether-chloroform as eluants. Its IR spectrum exhibited
characteristic absorption band for hydroxyl group (3318
cm-1) and long aliphatic chain (721 cm−1). The mass
spectrum of OC showed molecular ion peak at m/z 411
[M+1]+ corresponding to a molecular formula of ans. Exponential phase promastigotes (2 × 106 cells ml-1) were incubated
escribed in Methods.
Figure 8 Estimation of GI50 of OC against promastigotes.
Parasites (2 × 106 cells ml-1) were incubated with serial three-fold
dilutions of OC (starting at 100 μg ml-1) for 96 h and viability was
determined microscopically as described in Methods. Each point
corresponds to the mean ± SE of triplicate samples and data is from
one of three experiments.
Figure 7 Reversibility analysis of treated promastigotes
revealed no reversion of growth in OC and pentamidine
treated samples.
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325 [CH3(CH2)20CHOH]
+ indicated the presence of the
hydroxyl group at C-7. The 1H NMR spectrum of OC
(Figure 1) showed a one proton broad multiplet at δ 3.67
with half width of 14.1 Hz was ascribed to α-oriented H-7
carbinol proton. The methylene protons resonated bet-
ween δ 2.36-1.34. Two three-proton triplets at δ 0.98
(J= 6.0) and 0.95 (J= 6.8) were accounted to C-1 and C-28
primary methyl proton respectively. The 13C NMR spec-
trum of OC (Figure 2) displayed signals for carbinol car-
bon at δ 72.06 (C-7), methylene carbons between 37.50-
22.72 and methyl carbon at δ 14.16 (C-1, C-28). The
1H-1H COSY spectrum of OC (Figure 3) exhibited corre-
lations of Me-1 with H2-2 and H2-3; H-7 with H2-6, H2-5,
H2-8 and H2-9; and Me-28 with H2-27 and H2-26. The
absence of any proton singlet beyond δ 3.67 and carbon
signal after δ 72.06 in the down field region suggested
saturated nature of the molecule. On the basis of fore-
going account the structure of OC was elucidated as
n-octacosan-7β-ol (Figure 4).
Antibacterial and antifungal study
The values (mm) of inhibitory zones for the bacterial and
fungal strain are studied by disc diffusion method and re-
sults are mentioned in Table 1. The diameter of the zone
of inhibition is expressed in millimeter including the disc
(6 mm). The OC presented antimicrobial activity against
the Staphylococcus epidermidis, Escherichia coli, Candida
albicans and Aspergillus niger, showing the biggest inhi-
bition zones. The results of the Minimum inhibitory con-
centration (MIC), minimum bactericidal concentration
(MBC) and minimum fungicidal concentration (MFC) are
presented and mentioned in Table 2. The analyzed com-
pound OC expressed strong antibacterial and antifungal
potential.
In vitro antileishmanial activity by growth kinetics assay
The isolated OC was assayed for its cytotoxicity against
L. donovani promastigotes which exhibited time-dependent
killing of promastigotes at a concentration of 100 μg ml-1.
No viable parasites were observed after 2 and 3 days of in-
cubation with pentamidine andOC, respectively (Figure 5).
Untreated parasites proliferated at a normal rate.
Alteration of cellular morphology
Visual inspection by phase-contrast microscopy revealed
the onset of cell shrinkage and cytoplasmic condensation
upon treatment of promastigotes with OC (100 μg ml-1)
(Figure 6), marked by complete circularization of almost
all the cells at 96 h post-treatment. Similar morpho-
logical changes were observed in pentamidine-treated
parasites. Microscopic study indicated that the effect
was leishmanicidal rather than leishmanistatic.Growth reversibility assay
To confirm the lethal effect of OC for promastigotes,
treated and untreated parasites (from the growth kinetics
study) were washed and resuspended in fresh medium
and their viability was ascertained microscopically after
96 h of incubation. No viable parasites were detected after
incubation with OC, as it was also observed with pentami-
dine, confirming their leishmanicidal effect (Figure 7).
Figure 9 Determination of adverse toxicity of OC on
mammalian macrophages. Macrophages from peritoneal cavity of
mice were incubated for 72 h at 37°C in CO2 incubator with increasing
concentrations (50, 100, 150 and 200 μg ml-1) of OC or pentamidine
and viability ascertained. Each bar represents mean ± SE of triplicate
samples and data is representative of one of three independent
experiments.
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The viability of promastigotes after treatment with OC
was evaluated using a modified GI50 assay and its dem-
onstrated dose-dependent inhibition of parasite growth
with GI50 achieved at 5.35 μg ml
-1. The established antil-
eishmanial drug pentamidine, used as a positive con-
trol, showed a similar trend in dose-dependent parasiteFigure 10 Overview of isolation and characterization of (OC) and its akilling, with a GI50 of 2.9 μg ml
-1 (Figure 8). Exposure to
DMSO (0.2%), representing the highest concentration of
diluent, showed no loss of parasite viability.
Cytotoxicity on mammalian macrophages
Peritoneal macrophages were isolated from mice to
check for any adverse side effects of the bioactive OC,
using pentamidine as the reference drug. The cytoto-
xicity assay revealed that there was no adverse toxicity
of OC, even at 200 μg ml-1, on mammalian macrophages
(Figure 9).
Discussion
Natural products compounds have been the mainstay of
several drug discoveries since the early days of the anti-
biotic era due to challenge posed by antibiotic resistance.
Discovery and development of a new leads of antimi-
crobial drugs as well as many others could be better ex-
plained by reverse pharmacology which is an evolutionary
process, based on traditional knowledge which facilitates
not only to search experimental database for many novel
leads but also minimize time, money and toxicity since
several years. VL is considered as an opportunistic infec-
tion among immunocompromised patients and mainly
treated with toxic pentavalent antimonials, second line
drugs such as amphotericin B and pentamidine. Curren-
tly there is no vaccine and resistance to antimonialntimicrobial evolution.
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parenteral route of administration, is a matter of great
concern in endemic regions of developing countries [27].
Due to severe adverse and toxic profile of synthetic mole-
cules, it is essential requirement for routine screening for
safer bioactive compounds from medicinal, aromatic and
food plants. Hence there could be no doubt to search for
novel antimicrobial agent having antileishmanial potency
is one of the core challenges in the current drug discovery
programme and this worldwide problem. Previously re-
ports exhibited as anthelmintic [15] and nematocidal ac-
tivity from extract of F. parviflora [17] but still no report
of such activity by novel isolated molecule as n-octacosan-
7β-ol, OC (0.471% yield) may be a new hope for this wide-
spread problem.Conclusion
In this study we found that OC isolated from F. parviflora
having bactericidal, fungicidal and leishmanicidal activity
(Figure 10). In view of the ongoing challenge to introduce
new antimicrobial agent as well as potent leishmanicidal
drugs which showed dose dependent as well as time
dependent parasite killing rate, indicated the potency of
OC with respect to pentamidine are anticipated to provide
a fresh platform. This study showed that OC have potent
antibacterial and antifungal activities against S. epidermi-
dis, E. coli, C. albicans and A. niger. These results indicate
that the compound might be a practical application in the
prevention and protection against bacterial (gram + and
gram-), fungal and leishmanial infections in animals and
humans.
Abbreviations
OC: n-octacosan-7β-ol; VL: Visceral leishmaniasis.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
MJ carried out procurement, extraction, study, drafting and isolation work
along with AA, MA has made study design, supervise, interpretation of the
isolated compound and revision of the manuscript. MI and FA have
contributed in Antileishmanial study. All authors read and approved the final
manuscript.
Acknowledgement
The authors are very thank full to Central Council for Research in Unani
Medicine, New Delhi, India and Jamia Hamdard University, New Delhi, India, for
providing research and instrumental facility such as NMR, FT-IR and LC-MS.
Author details
1Phytochemistry research Lab., Department of Pharmacognosy and
Phytochemistry, Faculty of Pharmacy, Jamia Hamdard, New Delhi 110062,
India. 2Parasite Immunology Lab., Department of Biotechnology, Faculty of
Science, Jamia Hamdard, New Delhi 110062, India.
Received: 13 November 2013 Accepted: 5 March 2014
Published: 12 March 2014References
1. Frantz S: Approvals: the demise of the blockbuster. Nat Rev Drug Discov
2004, 4:93–94.
2. Fakim AG: Medicinal plants: traditions of yesterday and drugs of
tomorrow. Mol Asp Med 2006, 27:1–93.
3. Ayensu ES, De- Filipps RA: Endangered and Threatened Plants of the United
States. Washington, DC: Smithsonian Institution; 1978.
4. Verpoorte R: Pharmacognosy in the new millennium: lead finding and
biotechnology. J Pharm Pharmacol 2000, 52:253–262.
5. Mohammed A: Present status of herbal medicines in India. Journal of
herbal medicine and toxicology 2009, 3(2):1–7.
6. Orhan I, Sener B, Musharraf SG: Antioxidant and hepatoprotective activity
appraisal of four selected Fumaria species and their total phenol and
flavonoid quantities. Exp Toxicol Pathol 2010, 64(3):205–209.
7. Chopra RN, Nayar SL, Chopra SN: Glossary of Indian Medicinal Plants.
New Delhi: National Institute of Science Communication and Information
Resources (CSIR); 2002:122.
8. Mossa JS, Al-Yahya MA, Al- Meshal IA: Medicinal Plants of Saudi Arabia,
1st ed. Riyadh. ISBN 9960-36- 476–3.
9. Popova ME, Simanek V, Dolejs L, Smysl B, Preininger V: Alkaloids from
Fumaria parviflora and Fumaria Kralikii. Planta Med 1982, 45:120–122.
10. Rahman AU, Bhati MK, Choudhary MI, Sener B: Chemical constituents of
Fumaria indica. Fitoterapia 1992, 63:129–135.
11. Khattak SG, Gilani SN, Ikram M: Antipyretic studies on some indigenous
Pakistani medicinal plants. J Ethnopharmacol 1985, 14:45–51.
12. Gilani AH, Janbaz KH, Akhtar MS: Selective protective effect of the extract
from Fumaria parviflora on paracetamol-induced hepatotoxicity.
Gen Pharmacol 1996, 27:979–983.
13. Akhtar MS, Khan QM, Khaliq T: Effect of Euphorbia prostrate and Fumaria
indica in normoglycemic and alloxan-treated hyperglycemic rabbits.
Planta Med 1984, 50:140–142.
14. Rehman N, Bashir S, Al-Rehaily AJ, Gilani AH: Mechanisms underlying the
antidiarrheal, antispasmodic and bronchodilator activities of Fumaria
parviflora and involvement of tissue and species specificity.
J Ethnopharmacol 2012, 144:128–137.
15. Hordgen P, Hertzberg H, Heilmann J, Langhans W, Maurer V: The
anthelmintic efficacy of five plant products against gastrointestinal
trichostrongylids in artificially infected lambs. Veterinary Parasitolgy 2003,
117:51–60.
16. Jowkar F, Jamshidzadeh A, Yazdi AM, Pasalar M: The effects of Fumaria
Parviflora L extract on chronic hand eczema: a randomized double-blind
placebo controlled clinical trial. Iranian Red Crescent Medical Journal 2011,
13(11):824–828.
17. Naz I, Rius JEP, Saifullah Blok V, Khan MR, Ali S, Ali S: vitro and in planta
nematicidal activity of Fumaria parviflora (Fumariaceae) against the
southern root-knot nematode Meloidogyne incognita. Plant Pathol 2012.
Doi: 10.1111/j.1365-3059.2012.02682.x.
18. Anonymous: Control of the leishmanaisis. Report of a WHO expert
committee. World Health Organ Tech Rep Ser 1990, 793:1–158.
19. Khalid SA, Farouk A, Geary TG, Jensen JB: Potential antimalarial candidates
from African plants: an in vitro approach using Plasmodium falciparum.
J Ethanopharmacol 1986, 15:201–209.
20. Singh N, Kumar A, Gupta P, Chand K, Samant M, Maurya R, Dube A:
Evaluation of antileishmanial potential of Tinospora sinensis against
experimental visceral leishmaniasis. Parasitol Res 2008, 102(3):561–565.
21. Afrin F, Rajesh R, Anam K, Gopinath M, Pal S, Ali N: Characterization of
Leishmania donovani antigens encapsulated in liposomes that
induce protective immunity in BALB/c mice. Infect Immun 2002,
70:6697–6706.
22. Hernandez T, Canales M, Avila JG, García AM, Martínez A, Caballero J,
Romo de Vivar A, Lira R: Composition and antibacterial activity of
essential oil of Lantana achyranthifolia Desf. (Verbenaceae).
J Ethnopharmacol 2005, 96:551–554.
23. Jones ME: Reinterpretation of Susceptibility Data Using Current NCCLS
Breakpoint Criteria. Antimicrob Agents Chemother 2003, 47(2):830.
24. Afrin F, Dey T, Anam K, Ali N: Leishmanicidal activity of stearylamine-
bearing liposomes in vitro. J Parasitol 2001, 87:188–193.
25. Dutta A, Ghoshal A, Mandal D, Mondal NB, Banerjee S, Sahu NP, Mandal C:
Racemoside A, an anti-leishmanial, watersoluble, natural steroidal
saponin, induces programmed cell death in Leishmania donovani.
J Med Microbiol 2007, 56:1196–1204.
Jameel et al. BMC Complementary and Alternative Medicine 2014, 14:98 Page 9 of 9
http://www.biomedcentral.com/1472-6882/14/9826. Islamuddin M, Farooque A, Dwarakanath BS, Sahal B, Afrin F: Extracts of
Artemisia annua leaves and seeds mediate programmed cell death in
Leishmania donovani. J Med Microbiol 2012, 61:1709–1718.
27. Sundar S, More DK, Singh MK, Singh VP, Sharma S, Makharia A, Kumar PC,
Murray HW: Failure of pentavalent antimony in visceral leishmaniasis in
India: report from the center of the Indian epidemic. Clin Infect Dis 2000,
31:1104–1107.
doi:10.1186/1472-6882-14-98
Cite this article as: Jameel et al.: Isolation, characterization and
antimicrobial evaluation of a novel compound N-octacosan 7β ol, from
Fumaria parviflora Lam. BMC Complementary and Alternative Medicine
2014 14:98.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
